Overview

CYP2B6 Polymorphisms in Ketamine

Status:
Completed
Trial end date:
2017-05-01
Target enrollment:
Participant gender:
Summary
This research study will determine if genetic variation in CYP2B6 affects how the body metabolizes ketamine.
Phase:
N/A
Details
Lead Sponsor:
Washington University School of Medicine
Treatments:
Ketamine